Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
918.52
-2.97 (-0.32%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
98
99
Next >
Novo Nordisk's 'Miracle' Weight Loss Drug Ozempic Linked To 48% Lower Risk Of Dementia, Study Finds
July 12, 2024
Novo Nordisk has found that its diabetes drug, Ozempic, is linked to a significant reduction in the risk of dementia and other cognitive issues.
Via
Benzinga
Eli Lilly, Novo Nordisk Shares Dip As Pfizer Ramps Up Diabetes Drug Competition
July 11, 2024
Shares of Eli Lilly and Co (NYSE: LLY) and Novo Nordisk A/S (NYSE: NVO) are facing declines Thursday, maybe influenced by competitive developments and regulatory updates in the pharmaceutical sector.
Via
Benzinga
Bernie Sanders Targets High Prices of Ozempic and Wegovy In US
July 11, 2024
Senator Bernie Sanders is pushing Novo Nordisk to lower U.S. prices for weight-loss drugs Ozempic and Wegovy, as part of a broader effort to reduce drug costs and expand Medicare price negotiations.
Via
Benzinga
3 Future Blue-Chip Stocks That Could Make You Rich
July 11, 2024
Blue-chip stocks are the cream of the crop of the stock exchange market. Find out about the best future blue-chip stocks to invest in.
Via
InvestorPlace
Better Growth Play: Eli Lilly vs. Vanguard Growth Index Fund ETF Shares
July 11, 2024
Both equities have been incredible growth plays of late.
Via
The Motley Fool
Topics
ETFs
Eli Lilly Announces CFO Change
July 10, 2024
Shares of Eli Lilly And Company (NYSE: LLY) are moving higher on Wednesday. Here's what you need to know.
Via
Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly and Co
July 09, 2024
Via
Benzinga
Warren Buffett Recommends This Magnificent Index Fund. It Could Turn $500 Per Month Into $986,900
July 11, 2024
The S&P 500 is a group of businesses that are bound to perform well over time, according to Warren Buffett.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Jim Cramer Identifies Eight Companies Eyeing Trillion-Dollar Club — Elon Musk's Tesla, Eli Lilly Top Contenders
July 11, 2024
Jim Cramer has identified eight companies that could potentially reach a market cap of $1 trillion, including Elon Musk's Tesla, and Eli Lilly.
Via
Benzinga
3 Pharma Stocks That Could Make Your Grandchildren Rich
July 10, 2024
Investors might want to consider the top pharma stocks in the current environment as they are beating most others.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
July 10, 2024
Via
Benzinga
Only 25% Patients Stick With Novo Nordisk's Wegovy Or Ozempic After 2 Years, A Study Shows; Company Calls Data Insufficient
July 10, 2024
A study shows that only one in four U.S. patients prescribed Novo Nordisk's weight-loss drugs Wegovy or Ozempic remain on the medication after two years, raising concerns about long-term adherence.
Via
Benzinga
Eli Lilly's $3.2B Morphic Deal Is 'Crucial,' Has 'Strategic Merit' Despite Investor Attention On Obesity: Analyst
July 09, 2024
Eli Lilly's acquisition of Morphic highlights strategic expansion in Immunology, targeting α4β7 for ulcerative colitis and Crohn's disease treatments. Goldman Sachs notes the deal's potential to...
Via
Benzinga
Hot Stocks: 3 Sleeping Giants About to Dominate Their Sectors
July 09, 2024
Give some consideration to these names, each of which has a strong competitive advantage and catalysts driving their share price higher.
Via
InvestorPlace
3 Moonshot Stocks With the Potential to Turn $10K Into $1 Million
July 09, 2024
Want to turn your $10K into $1 million? Here are three high-growth potential stocks that can make it happen for you.
Via
InvestorPlace
Summer 2024 Snapshot Of The S&P 500's Market Cap
July 09, 2024
The market capitalization of the S&P 500 grew by 4.2% during the course of the second quarter of 2024. The index ended 2024-Q2 with a market cap of $47.83 trillion according to Standard and Poor.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
7 Bullish Stock Picks With the Potential to Turn $5K Into $50K
July 09, 2024
These high-potential stock picks each have 10X potential moving forward and are well worth understanding despite high prices in some cases.
Via
InvestorPlace
Is Eli Lilly Stock a No-Brainer Buy After Its FDA Alzheimer's Disease Drug Win?
July 09, 2024
No matter how you look at it, the FDA approval of Kisunla is big for Eli Lilly.
Via
The Motley Fool
Exposures
Product Safety
Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?
July 09, 2024
This pharma company is posting double-digit revenue growth.
Via
The Motley Fool
S&P 500 Closes At Record High Ahead Of Inflation Data: Fear & Greed Index Remains In 'Neutral' Zone
July 09, 2024
The CNN Money Fear and Greed index slightly decreased, remaining in Neutral zone. US stocks mixed, with S&P 500 at record high.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows
July 09, 2024
Eli Lilly and Co has emerged victorious in the weight loss drug competition, in a recent study. The study found that patients on Lilly's Mounjaro lost more weight than those on Novo Nordisk's Ozempic.
Via
Benzinga
Patients Lost More Weight On Eli Lilly's Mounjaro Than Novo Nordisk's Ozempic
July 08, 2024
Patients lost more more weight on Mounjaro than Ozempic.
Via
Investor's Business Daily
A $2.5 Trillion Opportunity In The Biotech Industry
July 08, 2024
In 1979, Genentech managed to create synthetic human insulin. Now 45 years later, biotech is a $1.77 trillion industry — up from $1.55 trillion in 2023. By 2030, that’s projected to reach close to $4...
Via
Talk Markets
Facebook Parent Meta Platforms Among 4 Hot Stocks At All-Time Highs: Look For The Best Stocks On These IBD Lists
July 08, 2024
Meta Platforms came aboard the Big Cap Leaders list, as did medical standout Eli Lilly. They were among four stock at all-time highs Monday.
Via
Investor's Business Daily
Gold Falls Over 1%; HilleVax Shares Plunge
July 08, 2024
Via
Benzinga
3 Overlooked Giants-in-the-Making for Patient Investors
July 08, 2024
Consider buying into these overlooked growth stocks for long-term profits that will help to boost a portfolio and deliver riches.
Via
InvestorPlace
Dow Turns Lower; Myomo Shares Jump
July 08, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Stock Market News From Amazon, Nike, McCormick, and More
July 08, 2024
We also talk with author Nicola Twilley about her new book, "Frostbite: How Refrigeration Changed Our Food, Our Planet, and Ourselves."
Via
The Motley Fool
Why Is Morphic (MORF) Stock Up 75% Today?
July 08, 2024
Morphic stock is up on Monday after the company signed a deal with Eli Lilly for the acquisition of MORF shares at $57 each in cash.
Via
InvestorPlace
Eli Lilly's First Biotech Deal Of 2024, Buys Chronic Disease Player Morphic For $3.2B
July 08, 2024
Eli Lilly to acquire Morphic Holding Inc for $3.2 billion, strengthening its portfolio in chronic disease treatments. Morphic's lead program, MORF-057, targets inflammatory bowel disease, with...
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
98
99
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.